Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2

Interventions

Metformin 91Clomiphene 31Letrozole 23Inositol 19Folic Acid 11Chorionic Gonadotropin 11Exercise 10High-Intensity Interval Training 9drospirenone and ethinyl estradiol combination 8Ethinyl Estradiol 8Contraceptives, Oral 8Cholecalciferol 8cetrorelix 7Tablets 7Progesterone 7Menotropins 6follitropin alfa 5Pioglitazone 5Liraglutide 5Exenatide 5Cyproterone Acetate 5Caloric Restriction 5Vitamin D 4Triptorelin Pamoate 4Surveys and Questionnaires 4Sugars 4Spironolactone 4Glycoprotein Hormones, alpha Subunit 4Fish Oils 4Estradiol 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Polycystic Ovary Syndrome × ganirelix × Clear all
NCT05751252 2025-04-27

SOPKGANI

University Hospital, Lille

Phase EARLY_PHASE1 Completed
20 enrolled

Polycystic Ovary Syndrome

NCT00757185 2016-07-04

Compromised Microcirculation in Women With Polycystic Ovary Syndrome

Yale University

Phase EARLY_PHASE1 Completed
28 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡